Literature DB >> 15610734

Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism.

Li Shan1, Jeremy Vincent, Joseph S Brunzelle, Isabelle Dussault, Min Lin, Irina Ianculescu, Mark A Sherman, Barry M Forman, Elias J Fernandez.   

Abstract

The nuclear receptor CAR is a xenobiotic responsive transcription factor that plays a central role in the clearance of drugs and bilirubin while promoting cocaine and acetaminophen toxicity. In addition, CAR has established a "reverse" paradigm of nuclear receptor action where the receptor is active in the absence of ligand and inactive when bound to inverse agonists. We now report the crystal structure of murine CAR bound to the inverse agonist androstenol. Androstenol binds within the ligand binding pocket, but unlike many nuclear receptor ligands, it makes no contacts with helix H12/AF2. The transition from constitutive to basal activity (androstenol bound) appears to be associated with a ligand-induced kink between helices H10 and H11. This disrupts the previously predicted salt bridge that locks H12 in the transcriptionally active conformation. This mechanism of inverse agonism is distinct from traditional nuclear receptor antagonists thereby offering a new approach to receptor modulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15610734      PMCID: PMC2727924          DOI: 10.1016/j.molcel.2004.11.037

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  39 in total

1.  The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.

Authors:  P Wei; J Zhang; M Egan-Hafley; S Liang; D D Moore
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

2.  Detection, delineation, measurement and display of cavities in macromolecular structures.

Authors:  G J Kleywegt; T A Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-03-01

3.  Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors.

Authors:  Kendall W Nettles; Jun Sun; James T Radek; Shubin Sheng; Alice L Rodriguez; John A Katzenellenbogen; Benita S Katzenellenbogen; Geoffrey L Greene
Journal:  Mol Cell       Date:  2004-02-13       Impact factor: 17.970

4.  The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.

Authors:  Kelly Suino; Li Peng; Ross Reynolds; Yong Li; Ji-Young Cha; Joyce J Repa; Steven A Kliewer; H Eric Xu
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

5.  Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene.

Authors:  T Kawamoto; T Sueyoshi; I Zelko; R Moore; K Washburn; M Negishi
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

6.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

7.  Atomic structure of progesterone complexed with its receptor.

Authors:  S P Williams; P B Sigler
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

8.  Induction of bilirubin clearance by the constitutive androstane receptor (CAR).

Authors:  Wendong Huang; Jun Zhang; Steven S Chua; Mohammed Qatanani; Yunqing Han; Riccarda Granata; David D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

9.  A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity.

Authors:  Isabelle Dussault; Min Lin; Kevin Hollister; Ming Fan; John Termini; Mark A Sherman; Barry M Forman
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.

Authors:  Holger Greschik; Ralf Flaig; Jean-Paul Renaud; Dino Moras
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

View more
  44 in total

1.  Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation.

Authors:  Ryota Shizu; Makoto Osabe; Lalith Perera; Rick Moore; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

Review 2.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 3.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

4.  Nuclear receptors CAR and PXR in the regulation of hepatic metabolism.

Authors:  E S Tien; M Negishi
Journal:  Xenobiotica       Date:  2006 Oct-Nov       Impact factor: 1.908

5.  Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.

Authors:  Edward Wright; Jeremy Vincent; Elias J Fernandez
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

Review 6.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

Review 7.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

Review 8.  A current structural perspective on PXR and CAR in drug metabolism.

Authors:  Cameron D Buchman; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-05-30       Impact factor: 4.481

9.  Coupling of receptor conformation and ligand orientation determine graded activity.

Authors:  John B Bruning; Alexander A Parent; German Gil; Min Zhao; Jason Nowak; Margaret C Pace; Carolyn L Smith; Pavel V Afonine; Paul D Adams; John A Katzenellenbogen; Kendall W Nettles
Journal:  Nat Chem Biol       Date:  2010-10-10       Impact factor: 15.040

10.  Protein evolution by molecular tinkering: diversification of the nuclear receptor superfamily from a ligand-dependent ancestor.

Authors:  Jamie T Bridgham; Geeta N Eick; Claire Larroux; Kirti Deshpande; Michael J Harms; Marie E A Gauthier; Eric A Ortlund; Bernard M Degnan; Joseph W Thornton
Journal:  PLoS Biol       Date:  2010-10-05       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.